Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cuddling baby eases Post-Birth stitching pain, study finds

NCT ID NCT07471724

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether holding a baby skin-to-skin or cheek-to-cheek can help control pain during and after episiotomy repair (stitches after birth). 155 healthy new mothers were randomly assigned to skin-to-skin contact, cheek contact, or standard care. Results showed that both types of contact may reduce pain and improve breastfeeding, offering a simple, drug-free way to support mothers after delivery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

155 people

The number who actually took part.

Started

Apr 2024

Finished

Nov 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged 18 years or older Able to speak and understand Turkish Singleton pregnancy at ≥37 gestational weeks Spontaneous vaginal birth with mediolateral episiotomy Mother and newborn clinically stable after birth Newborn APGAR score ≥7 at 1 and 5 minutes Willingness to participate and provision of informed consent Exclusion Criteria: * Operative vaginal birth (vacuum or forceps) Third- or fourth-degree perineal tear or extensive perineal laceration Epidural analgesia during labor Maternal or neonatal complications requiring medical intervention Conditions requiring maternal-infant separation after birth Refusal to participate in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Episiotomy pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ege University

    Izmir, İmbatlı Mah, 35400, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.